Monocytes in the tumor microenvironment

S Ugel, S Canè, F De Sanctis… - Annual Review of …, 2021 - annualreviews.org
Immunotherapy has revolutionized cancer treatment over the past decade. Nonetheless,
prolonged survival is limited to relatively few patients. Cancers enforce a multifaceted …

Monocyte heterogeneity and functions in cancer

CE Olingy, HQ Dinh, CC Hedrick - Journal of leukocyte biology, 2019 - academic.oup.com
Monocytes are innate immune cells of the mononuclear phagocyte system that have
emerged as important regulators of cancer development and progression. Our …

[HTML][HTML] Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity

E Duong, TB Fessenden, E Lutz, T Dinter, L Yim, S Blatt… - Immunity, 2022 - cell.com
Tumor-infiltrating dendritic cells (DCs) assume varied functional states that impact anti-tumor
immunity. To delineate the DC states associated with productive anti-tumor T cell immunity …

[HTML][HTML] Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

Y Xiao, J Chen, H Zhou, X Zeng, Z Ruan, Z Pu… - Nature …, 2022 - nature.com
Immunotherapy with immune checkpoint blockade (ICB) has shown limited benefits in
hepatocellular carcinoma (HCC) and other cancers, mediated in part by the …

A peritumorally injected immunomodulating adjuvant elicits robust and safe metalloimmunotherapy against solid tumors

L Zhang, J Zhao, X Hu, C Wang, Y Jia, C Zhu… - Advanced …, 2022 - Wiley Online Library
Clinical immunotherapy of solid tumors elicits durable responses only in a minority of
patients, largely due to the highly immunosuppressive tumor microenvironment (TME) …

[HTML][HTML] Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses

JK Mandula, S Chang, E Mohamed, R Jimenez… - Cancer Cell, 2022 - cell.com
Activation of unfolded protein responses (UPRs) in cancer cells undergoing endoplasmic
reticulum (ER) stress promotes survival. However, how UPR in tumor cells impacts anti …

[HTML][HTML] Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

Z Zhu, AJR McGray, W Jiang, B Lu, P Kalinski, ZS Guo - Molecular cancer, 2022 - Springer
Oncolytic viruses (OVs) represent a new class of multi-modal immunotherapies for cancer,
with OV-elicited antitumor immunity being key to their overall therapeutic efficacy. Currently …

p53, cancer and the immune response

J Blagih, MD Buck, KH Vousden - Journal of cell science, 2020 - journals.biologists.com
The importance of cancer-cell-autonomous functions of the tumour suppressor p53
(encoded by TP53) has been established in many studies, but it is now clear that the p53 …

[HTML][HTML] The ontogeny of monocyte subsets

AA Wolf, A Yáñez, PK Barman… - Frontiers in …, 2019 - frontiersin.org
Classical and non-classical monocytes, and the macrophages and monocyte-derived
dendritic cells they produce, play key roles in host defense against pathogens, immune …

[HTML][HTML] Chemokines and the immune response to cancer

AJ Ozga, MT Chow, AD Luster - Immunity, 2021 - cell.com
Chemokines are chemotactic cytokines that regulate the migration of immune cells.
Chemokines function as cues for the coordinated recruitment of immune cells into and out of …